110 related articles for article (PubMed ID: 18034978)
1. Sublingual immunotherapy-induced IL-10 production is associated with changed response to the decongestion test: preliminary results.
Ciprandi G; Cirillo I; Tosca MA; Marseglia G; Fenoglio D
Allergy Asthma Proc; 2007; 28(5):574-7. PubMed ID: 18034978
[TBL] [Abstract][Full Text] [Related]
2. Association between response to decongestion testing and sensitizations and allergic inflammation.
Ciprandi G; Cirillo I; Klersy C; Vizzaccaro A; Tosca MA; Marseglia GL
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):431-6. PubMed ID: 16597077
[TBL] [Abstract][Full Text] [Related]
3. Decongestion test in patients with allergic rhinitis: functional evaluation of nasal airflow.
Ciprandi G; Cirillo I; Vizzaccaro A; Pallestrini E; Tosca MA
Am J Rhinol; 2006; 20(2):224-6. PubMed ID: 16686394
[TBL] [Abstract][Full Text] [Related]
4. Nasal eosinophils and reversibility to the decongestion test in patients with perennial allergic rhinitis.
Ciprandi G; Cirillo I; Klersy C; Tosca MA; Marseglia GL
Allergy Asthma Proc; 2007; 28(3):292-5. PubMed ID: 17619557
[TBL] [Abstract][Full Text] [Related]
5. Ebastine improves nasal symptoms and airflow and affects response to decongestion test in patients with persistent allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Mora F; La Rosa M
Allergy Asthma Proc; 2007; 28(5):578-81. PubMed ID: 17883885
[TBL] [Abstract][Full Text] [Related]
6. Clinical assessment of a nasal decongestion test by visual analog scale in allergic rhinitis.
Ciprandi G; Klersy C; Ameli F; Cirillo I
Am J Rhinol; 2008; 22(5):502-5. PubMed ID: 18954509
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy induces spirometric improvement associated with IL-10 production: preliminary reports.
Ciprandi G; Cirillo I; Fenoglio D; Marseglia G; Tosca MA
Int Immunopharmacol; 2006 Aug; 6(8):1370-3. PubMed ID: 16782551
[TBL] [Abstract][Full Text] [Related]
8. Relationship between rhinitis duration and response to nasal decongestion test.
Ciprandi G; Pistorio A; Tosca M; Cirillo I
Laryngoscope; 2008 Jul; 118(7):1139-41. PubMed ID: 18425049
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
10. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report.
Ciprandi G; Fenoglio D; Cirillo I; Vizzaccaro A; Ferrera A; Tosca MA; Puppo F
Ann Allergy Asthma Immunol; 2005 Jul; 95(1):38-44. PubMed ID: 16095140
[TBL] [Abstract][Full Text] [Related]
11. Clinical assessment of nasal decongestion test by VAS in adolescents.
Marseglia GL; Cirillo I; Klersy C; Caimmi D; Caimmi S; Castellazzi AM; Ciprandi G
Pediatr Allergy Immunol; 2009 Mar; 20(2):187-91. PubMed ID: 18422891
[TBL] [Abstract][Full Text] [Related]
12. Comparison of nasal sound spectral analysis and peak nasal inspiratory flow before and after decongestion in patients with nasal obstruction.
Choi H; Park IH; Yoon HG; Lee HM
Ann Otol Rhinol Laryngol; 2011 Jun; 120(6):391-6. PubMed ID: 21774447
[TBL] [Abstract][Full Text] [Related]
13. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis.
Bozek A; Ignasiak B; Filipowska B; Jarzab J
Clin Exp Allergy; 2013 Feb; 43(2):242-8. PubMed ID: 23331565
[TBL] [Abstract][Full Text] [Related]
14. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H
Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of sublingual immunotherapy of allergic rhinitis in children between 4 and 5 years age group and 11 and 12 years age group].
Cui L; Wang ZN; Xu ZQ; Xia ZF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jan; 48(1):17-21. PubMed ID: 23656810
[TBL] [Abstract][Full Text] [Related]
16. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in allergic rhinitis: relationship with clinical, immunological, and functional aspects.
Ciprandi G; Klersy C; Cirillo I; Marseglia GL
Clin Exp Allergy; 2007 Oct; 37(10):1528-35. PubMed ID: 17883732
[TBL] [Abstract][Full Text] [Related]
18. Nasal decongestion test in allergic rhinitis: definition of responder.
Ciprandi G; Cirillo I; Klersy C; Castellazzi AM; Barberi S; Marseglia GL
Int Immunopharmacol; 2007 Mar; 7(3):372-4. PubMed ID: 17276895
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
[TBL] [Abstract][Full Text] [Related]
20. Sublingual specific immunotherapy reduces PBMC proliferations.
Fenoglio D; Puppo F; Cirillo I; Vizzaccaro A; Ferrera A; Tosca MA; Marseglia G; Ciprandi G
Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):147-51. PubMed ID: 15916016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
